Mynvax (India)
Mynvax, a clinical stage vaccine biotechnology company, was founded with the singular vision of developing novel, improved, recombinant, thermostable vaccines to protect against respiratory viral infections. Mynvax was named as one of the seven Indian vaccine companies working on developing vaccines for COVID-19. Mynvax has successfully demonstrated its vaccine design capabilities by quickly developing a thermotolerant COVID-19 vaccine formulation, efficacious against earlier and current viral v
Basic Information
- Category: business
- Founded: 2017
- Website: https://www.mynvax.com
Documented Facts
- Email: info@mynvax.com (No linked source recorded for this statement.)
- Founded: 2017 (No linked source recorded for this statement.)
Evidence and Sources
- Mynvax (India) — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Mynvax (India).
- Canonical profile: https://brandsource.ai/brands/mynvax-india
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/mynvax-india/json-ld
- Citation profile API: https://brandsource.ai/api/brands/mynvax-india/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (80/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Mynvax, a clinical stage vaccine biotechnology company, was founded with the singular vision of developing novel, improved, recombinant, thermostable vaccines to protect against respiratory viral infections. Mynvax was named as one of the seven Indian vaccine companies working on developing vaccines for COVID-19. Mynvax has successfully demonstrated its vaccine design capabilities by quickly developing a thermotolerant COVID-19 vaccine formulation, efficacious against earlier and current viral v
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.